Coiled interactions

Two-hybrid assays are great for detecting protein-protein interactions, but they scale as the square of the number of candidate interactions. Screening every possible interaction in yeast would require examining approximately 3.6 x 107 pairs, which is why previous large-scale screens by Uetz et al. and Ito et al. have pooled libraries of constructs. In the November 21 Proceedings of the National Academy of Sciences, Newman et al. find that such approaches can miss a great number of valid interac

Written byWilliam Wells
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Two-hybrid assays are great for detecting protein-protein interactions, but they scale as the square of the number of candidate interactions. Screening every possible interaction in yeast would require examining approximately 3.6 x 107 pairs, which is why previous large-scale screens by Uetz et al. and Ito et al. have pooled libraries of constructs. In the November 21 Proceedings of the National Academy of Sciences, Newman et al. find that such approaches can miss a great number of valid interactions (Proc Natl Acad Sci USA 2000, 97:13203-13208). Newman et al. approach the problem by first screening the yeast genome sequence computationally for the coiled-coil interaction motif, which consists of two or more helices that wrap around each other. They then analyze 162 coiled-coil sequences, selected on the basis of either their high predicted coil scores or their association with mitotic processes, and use two hybrid assays to find 213 unique interactions. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies